IOB.ch

🎉 We are delighted that our Director of Science, Botond Roska, has been elected to the German National Academy of Sciences Leopoldina (@Leopoldina), recognising his outstanding work in vision research and the development of new therapies for blindness. 👏 Congratulations, @IOB_Roska! 🔗 iob.ch/news-insights/… #VisionResearch #GeneTherapy #Optogenetics #TranslationalMedicine #Leopoldina

🚨 We're Hiring at IOB! 🔬👁️ The Ophthalmic Genetics Group at IOB is looking for a motivated "HiWi"/Student Research Assistant to join our team! 📍 Position: Student Research Assistant ⏳ Workload: 28% (12 hours/week) 📅 Contract: Fixed-term for 6 months 📩 Interested? Apply now or share this opportunity with students in your network who might be a great fit! jobs.unibas.ch/offene-stellen… #Hiring #HiWi #StudentJob #ResearchOpportunity #Ophthalmology #Genetics #StudentResearch #LifeSciences

📢 We're hiring a PostDoc in Computational and Experimental Approaches to Visual Physiology at IOB (100%). Interested in how the visual system encodes information and how this knowledge can help patients? Join us and tackle fundamental questions in vision science. iob.ch/education-care…

🔬 We're Hiring: Research Associate – Mitochondrial Therapy Translational (100%) Join the innovative team at IOB – Institute of Molecular and Clinical Ophthalmology Basel and contribute to cutting-edge translational research advancing mitochondrial therapies for eye diseases. 📍 Basel, Switzerland 🕒 Full-time (100%) Apply now or share with your network! iob.ch/education-care… #Hiring #ResearchAssociate #TranslationalResearch #Mitochondria #Basel

🏅His work on mitochondria has received recent recognition, including the Brain Diseases Award from the UZH Foundation, the 2026 RetinAward and Forbes Kazakhstan’s 30 Under 30 list.

🧪In a new Nature Reviews Molecular Cell Biology article, Ayupov outlines how MitoCatch can help address key challenges in mitochondrial transplantation: delivery efficiency, cell-type specificity and mechanistic tractability.

🚀Warm congratulations to @AyupovTemurkhan, appointed Group Leader at IOB. The new Mitochondrial Biology and Therapy Group studies mitochondrial dysfunction in neurodegeneration and develops targeted mitochondrial therapies using MitoCatch.

👏 Warm congratulations from IOB to Katherine A. High, Jean Bennett & Albert Maguire on the 2026 Breakthrough Prize in Life Sciences! Katherine High, CEO of our first spin-off, RhyGaze, brings scientific rigor together with a clear focus on delivering therapies for vision loss to patients. We are pleased to celebrate this well-deserved recognition! 🔗 More details: breakthroughprize.org/Laureates/2/L3…

👁‍🗨We turn science into sight. Congratulations to our Director @IOB_Roska on receiving the 2026 Future Vision Award alongside Connie Cepko & Daniel Ting. A recognition of long-term research now reaching patients. 🎬Watch the short movies: futurevisionfound.org/2026-films #Vision #Retina #Ophthalmology #Blindness #Neuroscience #ScienceInnovation #VisionRestoration #EyeHealth #BiomedicalResearch

The work could help to explain why the risk of developing some brain conditions — such as schizophrenia and Alzheimer’s disease — differs between males and females go.nature.com/486ipEn

Very nice News & Views article on our work by Samantha Krysa and Jonathan Brestoff. @Nature @NaturePortfolio @IOB_ch #MitoCatch #Mitochondria #Neurodegeneration nature.com/articles/d4158…

The mitochondrion-targeting tool MitoCatch brings mitochondria into specific cell types through cell-surface-targeted binders. #NBThighlight nature.com/articles/s4158…

🚀A potential paradigm shift for diseases linked to mitochondrial dysfunction. 📄 Published in @Nature: nature.com/articles/s4158… #MitoCatch #NatureJournal #Mitochondria #PrecisionMedicine #CellTherapy #Neuroscience #VisionResearch #BiotechInnovation #LHON #OpticNeuropathies

✨Key findings: MitoCatch delivers mitochondria to key cell types with higher efficiency. Transferred mitochondria remain functional and targeted cells’ survival is improved.

💡What if we could reboot sick cells? IOB scientists @AyupovTemurkhan, @v_moreno_juan and collaborators led by @IOB_Roska have developed #MitoCatch, a system that delivers healthy mitochondria directly to diseased cells. A step toward precision mitochondrial medicine. 🧵👇

🔬 #MitoCatch uses engineered protein binders, like a cellular GPS, to guide mitochondria exactly where they are needed. Three complementary versions of #MitoCatch enable targeted delivery.

⚡ Mitochondria power our cells. When they fail, diseases like optic nerve degeneration, Parkinson’s, or heart failure can follow. Getting healthy mitochondria to the right cells has been a major challenge.